BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Seok-Soo Byun, Woon Geol Yeo, Sang Eun Lee, Eunsik Lee. Expression of Survivin in Renal Cell Carcinomas: Association with Pathologic Features and Clinical OutcomeUrology 2007; 69(1): 34 doi: 10.1016/j.urology.2006.09.024
2
G. Ramakrishnan, L. Lo Muzio, C. M. Elinos-Báez, S. Jagan, T. A. Augustine, S. Kamaraj, P. Anandakumar, T. Devaki. Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cellsCell Proliferation 2009; 42(2): 229 doi: 10.1111/j.1365-2184.2008.00581.x
3
Gang Li, Hong Chang, Yun-Peng Zhai, Wei Xu. Targeted Silencing of Inhibitors of Apoptosis Proteins with siRNAs: A Potential Anti-cancer Strategy for Hepatocellular CarcinomaAsian Pacific Journal of Cancer Prevention 2013; 14(9): 4943 doi: 10.7314/APJCP.2013.14.9.4943
4
Chong Li, Ji Wang, Hong Zhang, Mingao Zhu, Feifei Chen, Yufeng Hu, Hudan Liu, Hong Zhu. Interferon-stimulated Gene 15 (ISG15) is a trigger for tumorigenesis and metastasis of hepatocellular carcinomaOncotarget 2014; 5(18): 8429 doi: 10.18632/oncotarget.2316
5
WENSONG LIU, FENG ZHU, YONG JIANG, DONGLIN SUN, BO YANG, HAIJIAO YAN. siRNA targeting survivin inhibits the growth and enhances the chemosensitivity of hepatocellular carcinoma cellsOncology Reports 2013; 29(3): 1183 doi: 10.3892/or.2012.2196
6
Chengquan Ma, Bingxin Lu, Erlin Sun. Clinicopathological and prognostic significance of survivin expression in renal cancer patients: a meta-analysisPostgraduate Medical Journal 2017; 93(1098): 186 doi: 10.1136/postgradmedj-2016-134105
7
Giueng-Chueng Wang, Po-Shiuan Hsieh, Hsian-He Hsu, Guang-Huan Sun, Shin Nieh, Cheng-Ping Yu, Jong-Shiaw Jin. Expression of cortactin and survivin in renal cell carcinoma associated with tumor aggressivenessWorld Journal of Urology 2009; 27(4): 557 doi: 10.1007/s00345-009-0376-2
8
XIAOBO JIA, YINGTANG GAO, DAOKUAN ZHAI, JIAO LIU, YAJIE WANG, LI JING, ZHI DU. Survivin is not a promising serological maker for the diagnosis of hepatocellular carcinomaOncology Letters 2015; 9(5): 2347 doi: 10.3892/ol.2015.3050
9
RA Yenkejeh, MR Sam, M Esmaeillou. Targeting survivin with prodigiosin isolated from cell wall of Serratia marcescens induces apoptosis in hepatocellular carcinoma cellsHuman & Experimental Toxicology 2017; 36(4): 402 doi: 10.1177/0960327116651122
10
Felix H. Shek, Tracy C. W. Lai, Sarwat Fatima, Nikki P. Lee. New Advances on Disease Biomarkers and Molecular Targets in Biomedicine2013; : 57 doi: 10.1007/978-1-62703-456-2_4
11
Laetitia Fartoux, Thomas Decaens. Contribution of biomarkers and imaging in the management of hepatocellular carcinomaClinics and Research in Hepatology and Gastroenterology 2011; 35: S21 doi: 10.1016/S2210-7401(11)70004-3
12
MENG WANG, BAO-GANG LIU, ZHAO-YANG YANG, XUAN HONG, GONG-YAN CHEN. Significance of survivin expression: Prognostic value and survival in stage III non-small cell lung cancerExperimental and Therapeutic Medicine 2012; 3(6): 983 doi: 10.3892/etm.2012.512
13
Guru Prasad Sharma, Sumiran Kumar Gurung, Afreen Inam, Lokesh Nigam, Archana Bist, Debasish Mohapatra, Shantibhusan Senapati, Naidu Subbarao, Amir Azam, Neelima Mondal. CID-6033590 inhibits p38MAPK pathway and induces S-phase cell cycle arrest and apoptosis in DU145 and PC-3 cellsToxicology in Vitro 2019; 60: 420 doi: 10.1016/j.tiv.2019.06.003
14
Eiman Adel Hasby, Mohammed Alaa Mokhtar. Survivin immunohistochemical expression in hepatocellular carcinoma: Correlation with tumour differentiation and proliferationArab Journal of Gastroenterology 2010; 11(3): 141 doi: 10.1016/j.ajg.2010.07.001
15
Cheng-Jeng Tai, Hung Chin-Sheng, Li-Jen Kuo, Po-Li Wei, Hsuan-Hsuan Lu, Hsin-An Chen, Tsan-Zon Liu, Jun-Jen Liu, Der-Zen Liu, Yuan-Soon Ho, Chih-Hsiung Wu, Yu-Jia Chang. Survivin-Mediated Cancer Cell Migration Through GRP78 and Epithelial-Mesenchymal Transition (EMT) Marker Expression in Mahlavu CellsAnnals of Surgical Oncology 2012; 19(1): 336 doi: 10.1245/s10434-011-1692-5
16
Isabel Fabregat. Dysregulation of apoptosis in hepatocellular carcinoma cellsWorld Journal of Gastroenterology 2009; 15(5): 513-520 doi: 10.3748/wjg.15.513
17
Thomas J. Vogl, Elsie Oppermann, Jun Qian, Ulli Imlau, Andreas Tran, Yousef Hamidavi, Huedayi Korkusuz, Wolf Otto Bechstein, Nour-Eldin Abdel-Rehim Nour-Eldin, Tatjana Gruber-Rouh, Renate Hammerstingl, Nagy Naguib Naeem Naguib. Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocolBMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2357-3
18
Y.W. Sun, Q. Xuan, Q.A. Shu, S.S. Wu, H. Chen, J. Xiao, P. Xiang, Y.P. Zhu, F.L. Wang, S.T. Zhao. Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinomaGenetics and Molecular Research 2013; 12(2): 1045 doi: 10.4238/2013.April.2.21
19
Che-Jen Hsiao, George Hsiao, Wei-Lin Chen, Shih-Wei Wang, Chun-Ping Chiang, Li-Ya Liu, Jih-Hwa Guh, Tzong-Huei Lee, Chi-Li Chung. Cephalochromin Induces G0/G1 Cell Cycle Arrest and Apoptosis in A549 Human Non-Small-Cell Lung Cancer Cells by Inflicting Mitochondrial DisruptionJournal of Natural Products 2014; 77(4): 758 doi: 10.1021/np400517g
20
G-Y Chau, A F-Y Lee, S-H Tsay, Y-R Ke, H-L Kao, F-H Wong, A-P Tsou, Y-P Chau. Clinicopathological significance of survivin expression in patients with hepatocellular carcinomaHistopathology 2007; 51(2): 204 doi: 10.1111/j.1365-2559.2007.02738.x
21
Yen-Shen Lu, Yoko Kashida, Samuel K. Kulp, Yu-Chieh Wang, Dasheng Wang, Jui-Hsiang Hung, Monica Tang, Zhong-Zhe Lin, Te-Jung Chen, Ann-Lii Cheng, Ching-Shih Chen. Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinomaHepatology 2007; 46(4): 1119 doi: 10.1002/hep.21804
22
José T. Stefano, Claudia P. M. S. de Oliveira, Maria L. Corrêa-Giannella, Iberê C. Soares, Marcia S. Kubrusly, Marta Bellodi-Privato, Evandro S. de Mello, Vicência M. R. de Lima, Flair J. Carrilho, Venancio A. F. Alves. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?Liver International 2011; 31(3): 377 doi: 10.1111/j.1478-3231.2010.02370.x